The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss.
about
Reaction of Cresyl Saligenin Phosphate, the Organophosphorus Agent Implicated in Aerotoxic Syndrome, with Human Cholinesterases: Mechanistic Studies Employing Kinetics, Mass Spectrometry, and X-ray Structure AnalysisFurther studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.Crystal structure of patatin-17 in complex with aged and non-aged organophosphorus compounds.Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.Analytical approaches for monitoring exposure to organophosphorus and carbamate agents through analysis of protein adducts.Kinetics and mechanism of inhibition of serine esterases by fluorinated aminophosphonates.Kinetics of inhibition of soluble peripheral nerve esterases by PMSF: a non-stable compound that potentiates the organophosphorus-induced delayed neurotoxicity.
P2860
Q27667321-C65C3103-4ABE-4D09-89E0-65228E0D199CQ33857017-0514E80B-9D2E-40C2-8BDB-B116AE3B1476Q34233205-557F3E72-1F8A-4E11-9BB4-89AEECFCA079Q35026594-56462AAC-C6A3-42E6-8202-F99B371ED609Q35572473-0DB3C0D3-1E72-489F-B9F3-A137809FEB42Q37987520-B5262EF5-99EA-4EB3-BEE6-1DF63C504395Q39856492-D753EC72-65DB-4357-8258-9F52BEFCB22CQ43853968-E1BAF7C2-C290-4550-B4D7-056270AB385E
P2860
The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The mipafox-inhibited catalyti ...... ges by reversible proton loss.
@ast
The mipafox-inhibited catalyti ...... ges by reversible proton loss.
@en
type
label
The mipafox-inhibited catalyti ...... ges by reversible proton loss.
@ast
The mipafox-inhibited catalyti ...... ges by reversible proton loss.
@en
prefLabel
The mipafox-inhibited catalyti ...... ges by reversible proton loss.
@ast
The mipafox-inhibited catalyti ...... ges by reversible proton loss.
@en
P2093
P356
P1433
P1476
The mipafox-inhibited catalyti ...... ges by reversible proton loss.
@en
P2093
Paul Glynn
Rudy J Richardson
Timothy J Kropp
P304
P356
10.1021/BI049960E
P407
P577
2004-03-01T00:00:00Z